Loading...
Recombinant human erythropoietin for treating severe traumatic brain injury
BACKGROUND: This study aimed to explore the efficacy and safety of recombinant human erythropoietin (RHE) for the treatment of severe traumatic brain injury (STBI). METHODS: One hundred and twenty eligible patients with STBI were randomly divided into an intervention group or a control group equally...
Saved in:
| Published in: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Wolters Kluwer Health
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5943123/ https://ncbi.nlm.nih.gov/pubmed/29505528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000009532 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|